MGMT and central nervous system cancer: Synergistically adding the epigenetic information to routine examinations, including MRI imaging, MGMT promoter methylation, IDH mutation, loss of 1p/19q, BRAF fusion, and CpG island methylator phenotype (CIMP), are of crucial and predictive significance for glioma diagnosis.